Influence of food intake on electrocardiograms of healthy male volunteers von WIDERLÖV, E, JOSTELL, K.-G, CLAESSON, L, ODLIND, B, KEISU, M, FREYSCHUSS, U

Volltext

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively von Widerlöv, E., Lindström, L.H., Wahlestedt, C., Ekman, R.

Volltext

Cerebrospinal fluid concentrations of neuropeptide Y in depressed patients and in controls von Gjerris, A, Widerlöv, E, Werdelin, L, Ekman, R

Volltext

Elevated Concentrations of CSF Corticotropin-Releasing Factor--Like Immunoreactivity in Depressed Patients von Nemeroff, Charles B., Widerlöv, Erik, Bissette, Garth, Walléus, Helena, Karlsson, Ingvar, Eklund, Kurt, Kilts, Clinton D., Loosen, Peter T., Vale, Wylie

Volltext

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models von HEILIG, M, SODERPALM, B, ENGEL, J. A, WIDERLOV, E

Volltext

Effects of intracerebroventricularly administered somatostatin on passive avoidance, shuttle-box behaviour and open-field activity in rats von VECSEI, L, WIDERLOV, E

Volltext

Arginine vasopressin, but not corticotropin releasing factor, is a potent stimulator of adrenocorticotropic hormone following electroconvulsive treatment von WIDERLÖV, E, EKMAN, R, JENSEN, L, BORGLUND, L, NYMAN, K

Volltext

Withdrawal effects in healthy volunteers following discontinuation of NAE-086, a selective 5-HT1A-receptor agonist. A possible model for SSRI withdrawal von Widerlöv, E., Jostell, K.-G., Undén, F.

Volltext

Increased CSF levels of endorphines in chronic psychosis von Terenius, L., Wahlström, A., Lindström, L., Widerlöv, E.

Volltext

Delta sleep-inducing peptide in CSF of patients with affective illness is elevated by lithium treatment von Regnéll, G., Widerlöv, E., Ekman, R.

Volltext

Neuropeptide Y (NPY)-induced suppression of activity in the rat: evidence for NPY receptor heterogeneity and for interaction with α-adrenoceptors von Heilig, Markus, Wahlestedt, Claes, Widerlöv, Erik

Volltext

Withdrawal effects in healthy volunteers following discontinuation of NAE-086, a selective 5-HT 1A-receptor agonist. A possible model for SSRI withdrawal von Widerlöv, E., Jostell, K.-G., Undén, F.

Volltext

Antidepressant drugs increase the concentration of neuropeptide Y (NPY)-like immunoreactivity in the rat brain von Heilig, Markus, Wahlestedt, Claes, Ekman, Rolf, Widerlöv, Erik

Volltext

An open study of remoxipride, a benzamide derivative, in schizophrenia von LINDSTROM, L, BESEV, G, STENING, G, WIDERLOV, E

Volltext

Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships von Widerlöv, E, Lewander, T

Volltext

Neuropeptide Y (NPY) and the central nervous system: Distribution effects and possible relationship to neurological and psychiatric disorders von Wahlestedt, Claes, Ekman, Rolf, Widerlöv, Erik

Volltext

Pharmacokinetics of remoxipride controlled release and immediate release capsules in schizophrenic patients von Widerlöv, E, Franzén, G, Jansson, P, Movin, G

Volltext

A Critical Appraisal of CSF Monoamine Metabolite Studies in Schizophrenia von WIDERLÖV, ERIK

Volltext

Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat von Wahlestedt, Claes, Blendy, Julie A., Kellar, Kenneth J., Heilig, Markus, Widerlo¨v, Erik, Ekman, Rolf

Volltext

Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man von WIDERLOV, E, TERMANDER, B, NILSSON, M.-I

Volltext